Discover 19 research papers published on
1st May, 2017 starting with "0"
0–π phase-controllable thermal Josephson junction
01 Linear programming methods for optimal normal and pseudo parameter reductions of soft sets
070 Liquid crystalline ordering of antimicrobial peptide-RNA complexes controls TLR3 activation
008–Case Study: 3 Year Old Female with Hypophosphatasia, Treated with Asfotase Alfa Replacement
055 Tissue resident memory T cell survival requires exogenous lipid uptake and metabolism
058 Non-lesional atopic dermatitis skin shares similar T cell clones with lesional tissues
017–Safety and Efficacy of Somavaratan (VRS-317), a Long-Acting Growth Hormone, in Children with Growth Hormone Deficiency (GHD): 2.5-Year Results from the VISTA Trial
016 Hyperactivation of Nrf2 contributes to keratinocyte hyperplasia in psoriasis by promoting Keratin 6, 16 and 17 expressions
002–Pediatric Diabetes Educators’ Use of Recommended Health Literacy Communication Techniques
015–Adherence to Treatment With ZOMAJET, a Needle-Free Device Transjecting Growth Hormone: Results of a French Observational Survey
071 Evaluation of soluble IgE receptors, sCD23, sFcεRI and Galectin-3, in sera from patients with Bullous pemphigoid
056 Anti-thyroid peroxidase antibodies may contribute to blister formation in pemphigus vulgaris
.014 versus .016 in Alignment and Leveling: Does it Make a Difference?
003–Screening for Depression in Adolescents with Type 1 Diabetes Mellitus
082 Systemic atopic dermatitis has different immune signatures
035 Temporally controlled B cell depletion with universal chimeric antigen receptor (CAR) T cells for pemphigus vulgaris (PV) therapy
060 Large-scale profiling of the auto-antibody response in pemphigus vulgaris identifies unique patterns of autoantibody reactivity that correlate to multiple disease parameters
010–Automated Insulin Delivery (Artificial Pancreas) on the Horizon: Educational Considerations for Youth with Type 1 Diabetes
001–Clinical Needs and Desires of Patients and Families Affected by Sex Chromosome Variations: Addressing Patent-Centered Care
01 Linear programming methods for optimal normal and pseudo parameter reductions of soft sets
070 Liquid crystalline ordering of antimicrobial peptide-RNA complexes controls TLR3 activation
008–Case Study: 3 Year Old Female with Hypophosphatasia, Treated with Asfotase Alfa Replacement
055 Tissue resident memory T cell survival requires exogenous lipid uptake and metabolism
058 Non-lesional atopic dermatitis skin shares similar T cell clones with lesional tissues
017–Safety and Efficacy of Somavaratan (VRS-317), a Long-Acting Growth Hormone, in Children with Growth Hormone Deficiency (GHD): 2.5-Year Results from the VISTA Trial
016 Hyperactivation of Nrf2 contributes to keratinocyte hyperplasia in psoriasis by promoting Keratin 6, 16 and 17 expressions
002–Pediatric Diabetes Educators’ Use of Recommended Health Literacy Communication Techniques
015–Adherence to Treatment With ZOMAJET, a Needle-Free Device Transjecting Growth Hormone: Results of a French Observational Survey
071 Evaluation of soluble IgE receptors, sCD23, sFcεRI and Galectin-3, in sera from patients with Bullous pemphigoid
056 Anti-thyroid peroxidase antibodies may contribute to blister formation in pemphigus vulgaris
.014 versus .016 in Alignment and Leveling: Does it Make a Difference?
003–Screening for Depression in Adolescents with Type 1 Diabetes Mellitus
082 Systemic atopic dermatitis has different immune signatures
035 Temporally controlled B cell depletion with universal chimeric antigen receptor (CAR) T cells for pemphigus vulgaris (PV) therapy
060 Large-scale profiling of the auto-antibody response in pemphigus vulgaris identifies unique patterns of autoantibody reactivity that correlate to multiple disease parameters
010–Automated Insulin Delivery (Artificial Pancreas) on the Horizon: Educational Considerations for Youth with Type 1 Diabetes
001–Clinical Needs and Desires of Patients and Families Affected by Sex Chromosome Variations: Addressing Patent-Centered Care